Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Anne C. Wilke"'
Autor:
Sebastian Scheich, Julius C Enßle, Victoria T Mücke, Fabian Acker, Lukas Aspacher, Sebastian Wolf, Anne C Wilke, Sarah Weber, Uta Brunnberg, Hubert Serve, Björn Steffen
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0225035 (2019)
Autologous hematopoietic stem cell transplantation (auto-HSCT) provides a potentially curative treatment option for relapsed and refractory lymphomas. Obesity displays an emerging epidemic risk factor for global mortality and is associated with an in
Externí odkaz:
https://doaj.org/article/96bbd8b99650499b9eb131015f2b0a66
Autor:
Sebastian Wolf, Constanze Schneider, Roland Schmitz, Kwang Seok Lee, Mikolaj Slabicki, Hans Christian Reinhardt, Henning Urlaub, Craig J. Thomas, Anne C. Wilke, Hubert Serve, Fernando Kreuz, Joshua D. Rabinowitz, Dominique Jahn, Michele Ceribelli, Christian Brandts, Kimberly Stegmaier, Matthew G. Vander Heiden, Caroline A. Lewis, Thomas Oellerich, Kamil Bojarczuk, Thorsten Zenz, Daniel J. Hodson, Sara A Rieke, Yana Pikman, James Q Wang, Xincheng Xu, Michael Engelke, Hahn Kim, Hanibal Bohnenberger, Zana A. Coulibaly, Clemens A Schmitt, Federico Comoglio, James D. Phelan, Louis M. Staudt, Carmen Doebele, Sebastian Scheich, Björn Chapuy, Frank Schnuetgen, Gero Knittel, Frances A. Tosto, Philipp Stroebel, Alena Zindel, Björn Häupl, Philipp Stauder, Thanh Hung Dang
Publikováno v:
Blood
Burkitt lymphoma (BL) is an aggressive lymphoma type that is currently treated by intensive chemoimmunotherapy. Despite the favorable clinical outcome for most patients with BL, chemotherapy-related toxicity and disease relapse remain major clinical
Autor:
Sebastian Scheich, Rosalie Koenig, Anne C Wilke, Sarah Lindner, Claudia Reinheimer, Thomas A Wichelhaus, Michael Hogardt, Volkhard A J Kempf, Johanna Kessel, Sarah Weber, Hans Martin, Gesine Bug, Hubert Serve, Björn Steffen
Publikováno v:
PLoS ONE, Vol 13, Iss 7, p e0201169 (2018)
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) offers potential cure to acute myeloid leukemia (AML) patients. However, infections with commensal bacteria are an important cause for non-relapse mortality (NRM). We have previously desc
Externí odkaz:
https://doaj.org/article/240619bb961043aeaf804f9dbc60a50c
Autor:
Sebastian Wolf, Ashok Kumar Jayavelu, Florian Buettner, Gabriela Alexe, Björn Häupl, Constanze Schneider, Anne C Wilke, Alena Zindel, Dominique Jahn, Bianca Splettstoesser, Julius Christoph Enssle, Anjali Cremer, Christoph Röllig, Christian Thiede, Björn Steffen, Martin Bornhäuser, Henning Urlaub, Kimberly Stegmaier, Hubert Serve, Matthias Mann, Thomas Oellerich
Publikováno v:
Blood. 140:3456-3457
Autor:
Olga Buzovetsky, Sebastian Scheich, Eva Wardelmann, Jindrich Cinatl, Sebastian Mohr, Martin Michaelis, Constanze Schneider, Wolfgang Hartmann, Yong Xiong, Thomas Oellerich, Kirsten M. Knecht, Hanibal Bohnenberger, Gerd Geisslinger, Federico Comoglio, Philipp Ströbel, Tamara Rothenburger, Oliver T. Keppler, Lars Kaderali, Christoph Schliemann, Dominique Thomas, Nerea Ferreirós, Anne C. Wilke, Hubert Serve, Linus Angenendt
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-14 (2019)
Nature Communications
Nature Communications
Hypomethylating agents decitabine and azacytidine are regarded as interchangeable in the treatment of acute myeloid leukemia (AML). However, their mechanisms of action remain incompletely understood, and predictive biomarkers for HMA efficacy are lac
Autor:
Ashok Kumar Jayavelu, Sebastian Wolf, Florian Buettner, Gabriela Alexe, Björn Häupl, Federico Comoglio, Constanze Schneider, Carmen Doebele, Dominik C. Fuhrmann, Sebastian Wagner, Elisa Donato, Carolin Andresen, Anne C. Wilke, Alena Zindel, Dominique Jahn, Bianca Splettstoesser, Uwe Plessmann, Silvia Münch, Khali Abou-El-Ardat, Philipp Makowka, Fabian Acker, Julius C. Enssle, Anjali Cremer, Frank Schnütgen, Nina Kurrle, Björn Chapuy, Jens Löber, Sylvia Hartmann, Peter J. Wild, Ilka Wittig, Daniel Hübschmann, Lars Kaderali, Jürgen Cox, Bernhard Brüne, Christoph Röllig, Christian Thiede, Björn Steffen, Martin Bornhäuser, Andreas Trumpp, Henning Urlaub, Kimberly Stegmaier, Hubert Serve, Matthias Mann, Thomas Oellerich
Publikováno v:
Cancer Cell. 40:301-317.e12
Acute myeloid leukemia (AML) is an aggressive blood cancer with a poor prognosis. We report a comprehensive proteogenomic analysis of bone marrow biopsies from 252 uniformly treated AML patients to elucidate the molecular pathophysiology of AML in or
Autor:
Ute Deppermann, Susann Theile, Maxim Kebenko, Anne C. Wilke, Hubert Serve, Felicitas Thol, Stefanie Amberg, Vera Schlipfenbacher, Franziska Modemann, Michael Heuser, Melanie Janning, Carsten Bokemeyer, Walter Fiedler, Joerg Chromik, Arnold Ganser, Anne L. Kranich
Publikováno v:
British Journal of Haematology. 190
Autor:
Piroska Klement, Walter Fiedler, Razif Gabdoulline, Louisa-Kristin Dallmann, Clara Wienecke, Johannes Schiller, Christian Kandziora, Katrin Teich, Bennet Heida, Maximilian Brandes, Carolin Funke, Martin Wichmann, Basem Othman, Jörg Chromik, Konstantin Büttner, Stefanie Amberg, Maxim Kebenko, Vera Schlipfenbacher, Anne C Wilke, Franziska Modemann, Melanie Janning, Hubert Serve, Carsten Bokemeyer, Ute Deppermann, Anne L. Kranich, Arnold Ganser, Felicitas Thol, Michael Heuser
Publikováno v:
Blood. 138:2369-2369
Introduction Selinexor is an exportin-1 (XPO1) inhibitor which forces the nuclear retention and functional activation of tumor suppressor proteins, inducing apoptosis in cancer cells. Overexpression of XPO-1 is common in many tumors, including acute
Autor:
Vladan Vucinic, Andrea Renzelmann, Monika Brüggemann, Stefan Schwartz, Nicola Goekbuget, Bernd Hertenstein, Andreas Viardot, Maria Wachsmuth, Andrea Stoltefuß, Max S. Topp, Christoph Faul, Lena Baumann, Diana Tichy, Anne C. Wilke
Publikováno v:
Blood. 138:3399-3399
Older patients (pts) with newly diagnosed ALL are ineligible for unmodified pediatric-based therapies. Even with age-adapted, dose-reduced regimens early death rates (ED) are considerable and overall survival (OS) poor. Thus, 412 pts treated accordin
Autor:
Rosalie Koenig, Thomas A. Wichelhaus, Volkhard A. J. Kempf, Björn Steffen, Silke Besier, Sarah Lindner, Johanna Kessel, Anne C. Wilke, Hubert Serve, Claudia Reinheimer, Michael Hogardt, Sebastian Scheich, Gesine Bug, Hans Martin
Publikováno v:
Cancer. 124:286-296
BACKGROUND Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment option for patients with acute myeloid leukemia (AML). During transplantation, patients undergo a period of severe neutropenia, which puts them at high